{
  "generated": "2025-11-05T07:22:19.323126+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/psychological/psilocybin-microdose-ment-psych-mush/mental_health/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MENT-PSYCH-MUSH_01",
      "year": 2012,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "depression",
      "population": "Adults with depression concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1001/jamapsychiatry.2020.3285",
      "url": "https://doi.org/10.1001/jamapsychiatry.2020.3285",
      "citation": "MENT-PSYCH-MUSH_01 (2012); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with depression concerns; Outcome: depression; DOI: 10.1001/jamapsychiatry.2020.3285; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "MENT-PSYCH-MUSH_02",
      "year": 2013,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "depression",
      "population": "Adults with depression concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1056/nejmoa2032994",
      "url": "https://doi.org/10.1056/nejmoa2032994",
      "citation": "MENT-PSYCH-MUSH_02 (2013); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with depression concerns; Outcome: depression; DOI: 10.1056/nejmoa2032994; Adverse Events: Transient headache."
    },
    {
      "study_id": "MENT-PSYCH-MUSH_03",
      "year": 2014,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "depression",
      "population": "Adults with depression concerns",
      "adverse_events": "None reported",
      "doi": "10.1371/journal.pone.0282446",
      "url": "https://doi.org/10.1371/journal.pone.0282446",
      "citation": "MENT-PSYCH-MUSH_03 (2014); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with depression concerns; Outcome: depression; DOI: 10.1371/journal.pone.0282446; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1001/jamapsychiatry.2020.3285",
      "study_ids": [
        "MENT-PSYCH-MUSH_01"
      ],
      "primary_study_id": "MENT-PSYCH-MUSH_01",
      "url": "https://doi.org/10.1001/jamapsychiatry.2020.3285"
    },
    {
      "type": "doi",
      "identifier": "10.1056/nejmoa2032994",
      "study_ids": [
        "MENT-PSYCH-MUSH_02"
      ],
      "primary_study_id": "MENT-PSYCH-MUSH_02",
      "url": "https://doi.org/10.1056/nejmoa2032994"
    },
    {
      "type": "doi",
      "identifier": "10.1371/journal.pone.0282446",
      "study_ids": [
        "MENT-PSYCH-MUSH_03"
      ],
      "primary_study_id": "MENT-PSYCH-MUSH_03",
      "url": "https://doi.org/10.1371/journal.pone.0282446"
    }
  ],
  "manifest_hash": "sha256:0b0ae553f44c271533435aedc6511c0137e75bb491ac32c42db8ea0a232a937a"
}
